Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408604![]() (US10358446, Compound 132) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408589![]() (US10358446, Compound 5) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408593![]() (US10358446, Compound 31) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408592![]() (US10358446, Compound 26) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408594![]() (US10358446, Compound 38) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408605![]() (US10358446, Compound 133) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408595![]() (US10358446, Compound 51) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408596![]() (US10358446, Compound 60) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408586![]() (US10358446, Compound 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408588![]() (US10358446, Compound 4) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408590![]() (US10358446, Compound 8) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408585![]() (US10358446, Compound 1 | US10358446, Compound 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408598![]() (US10358446, Compound 128) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408597![]() (US10358446, Compound 103) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408591![]() (US10358446, Compound 20) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408586![]() (US10358446, Compound 2) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408605![]() (US10358446, Compound 133) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408596![]() (US10358446, Compound 60) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408585![]() (US10358446, Compound 1 | US10358446, Compound 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408594![]() (US10358446, Compound 38) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408585![]() (US10358446, Compound 1 | US10358446, Compound 3) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408588![]() (US10358446, Compound 4) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408589![]() (US10358446, Compound 5) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM408606![]() (US10358446, Compound 138) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408591![]() (US10358446, Compound 20) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408595![]() (US10358446, Compound 51) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408606![]() (US10358446, Compound 138) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408604![]() (US10358446, Compound 132) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408593![]() (US10358446, Compound 31) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408590![]() (US10358446, Compound 8) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408597![]() (US10358446, Compound 103) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408598![]() (US10358446, Compound 128) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408592![]() (US10358446, Compound 26) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Blk (Homo sapiens (Human)) | BDBM408585![]() (US10358446, Compound 1 | US10358446, Compound 3) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408593![]() (US10358446, Compound 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408592![]() (US10358446, Compound 26) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408597![]() (US10358446, Compound 103) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408588![]() (US10358446, Compound 4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408591![]() (US10358446, Compound 20) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408588![]() (US10358446, Compound 4) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408590![]() (US10358446, Compound 8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408592![]() (US10358446, Compound 26) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408585![]() (US10358446, Compound 1 | US10358446, Compound 3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408594![]() (US10358446, Compound 38) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408604![]() (US10358446, Compound 132) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408598![]() (US10358446, Compound 128) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408597![]() (US10358446, Compound 103) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408594![]() (US10358446, Compound 38) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408598![]() (US10358446, Compound 128) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408605![]() (US10358446, Compound 133) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408585![]() (US10358446, Compound 1 | US10358446, Compound 3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408585![]() (US10358446, Compound 1 | US10358446, Compound 3) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408596![]() (US10358446, Compound 60) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408586![]() (US10358446, Compound 2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408593![]() (US10358446, Compound 31) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408595![]() (US10358446, Compound 51) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408589![]() (US10358446, Compound 5) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408606![]() (US10358446, Compound 138) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408595![]() (US10358446, Compound 51) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408596![]() (US10358446, Compound 60) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408586![]() (US10358446, Compound 2) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408604![]() (US10358446, Compound 132) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408606![]() (US10358446, Compound 138) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408591![]() (US10358446, Compound 20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408605![]() (US10358446, Compound 133) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lyn (Homo sapiens (Human)) | BDBM408589![]() (US10358446, Compound 5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase Lck (Homo sapiens (Human)) | BDBM408590![]() (US10358446, Compound 8) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO., LTD. US Patent | Assay Description Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume... | US Patent US10358446 (2019) BindingDB Entry DOI: 10.7270/Q2FJ2K4R | |||||||||||
More data for this Ligand-Target Pair |